Membrane protein-focused CRISPR screen identifies ATP2A2 as a druggable transcriptional co-regulator of CCND1 (cyclin D1) in lung adenocarcinoma
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Cancer-related Molecular Pathways
Lung Cancer Research Studies
Lung Cancer Treatments and Mutations
Publication details
- Journal / source
- Life Sciences
- Volume
- 394
- Pages
- 124358–124358
- Publication date
- 27 March 2026
- Language
- EN